Grow group: Biopharmaceutical company producing cannabis-based medicines.
Over the six months to June 30, 2022 the company reported £11.2k in revenues, which came entirely from LVL’s clinical study, up from no revenues in the same period a year earlier, with a gross loss of £12.4k. According to the company, this 5.7x rise in revenues was because of a 300% increase in the…